Announced at HIMSS26, the companies will deliver a bundled solution that unlocks advanced insights for study sponsors
Verily Life Sciences and Samsung Electronics America have announced a strategic collaboration to integrate Samsung’s Galaxy Watch 8 with Verily’s precision health platform, Pre. The partnership aims to accelerate clinical research and real-world health monitoring by combining consumer wearable data with advanced healthcare analytics, strengthening innovation in AI in healthcare and data-driven medical research.
The joint solution will enable life sciences organizations, research institutions, and government agencies to generate high-quality evidence from real-world patient populations. By integrating sensor data from the Samsung Galaxy Watch directly into Verily’s Viewpoint Evidence solution – built on the Verily Pre platform – research sponsors can access continuous health data to support large-scale clinical and observational studies.
Health Technology Insights: https://healthtechnologyinsights.com/what-is-ambient-clinical-intelligence-and-why-are-cios-talking-about-it/
Through the collaboration, Verily will incorporate wearable sensor data into its comprehensive research ecosystem. Sponsors will leverage Verily Pre data solutions such as Refinery for data harmonization and Workbench for analysis, modeling, and activation. The platform will also apply AI and machine learning analytics to interpret wearable-generated health insights, helping researchers better understand patient behavior, treatment outcomes, and long-term health trends.
Tyler Gipson, Senior Vice President of MX B2B at Samsung Electronics America, highlighted the significance of combining consumer health technology with clinical research infrastructure. Gipson stated, “The power of our Galaxy Watch lies not just in its consumer appeal but in its ability to generate high-quality, verified data.” “This partnership with Verily expedites the application of wearable data in clinical research, assisting sponsors in producing the empirical data required to develop novel treatments and enhance patient care.”
Samsung’s Galaxy Watch has already demonstrated reliability across multiple health measurements, including heart rate, blood oxygen levels, and body composition. The device has also received FDA clearance for key health features such as obstructive sleep apnea assessment and irregular heart rhythm notification, positioning it as a valuable tool for medical research and patient monitoring.
For research organizations, the partnership introduces several key capabilities. Sponsors will gain access to longitudinal datasets combining wearable sensor data, electronic medical records, surveys, and third-party health data. This unified dataset will allow researchers to study sleep patterns, physical activity, cardiovascular signals, and other health indicators over time.
Health Technology Insights: https://healthtechnologyinsights.com/what-are-smart-implants-and-bioprinting-doing-for-patient-care/
Additionally, sponsors will be able to design custom research programs using Verily’s registry of consented participants. These participants can be re-contacted for follow-up studies, enabling deeper insights into disease progression and treatment outcomes. Verily will also support participant recruitment and engagement among Samsung users to ensure consistent data capture and high-quality research participation.
Scott Burke, Chief Technology Officer at Verily, emphasized the broader vision behind the collaboration. He noted that integrating consumer-friendly wearable devices into clinical research simplifies participation while enabling advanced digital biomarkers to generate more accurate health insights.
As part of the partnership, Verily and Samsung will also explore the joint development of new end-to-end clinical research solutions that combine wearable technology, advanced analytics, and precision health tools. This initiative reflects a growing shift toward integrating everyday health technology with formal medical research, helping accelerate evidence generation and support the development of more personalized healthcare solutions.
Health Technology Insights: https://healthtechnologyinsights.com/how-data-intelligence-is-transforming-healthcare-and-life-sciences-innovation-right-now/
To participate in our interviews, please write to our HealthTech Media Room at info@intentamplify.com
